Cargando…
Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease or Charcot disease, is a fatal neurodegenerative disease that affects motor neurons (MNs) and leads to death within 2–5 years of diagnosis, without any effective therapy available. Although the pathological mechanisms leadi...
Autores principales: | Cunha-Oliveira, Teresa, Montezinho, Liliana, Mendes, Catarina, Firuzi, Omidreza, Saso, Luciano, Oliveira, Paulo J., Silva, Filomena S. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683149/ https://www.ncbi.nlm.nih.gov/pubmed/33274002 http://dx.doi.org/10.1155/2020/5021694 |
Ejemplares similares
-
Modulation of neurotrophic signaling pathways by polyphenols
por: Moosavi, Fatemeh, et al.
Publicado: (2015) -
Molecular biomarkers associated with respiratory insufficiency in amyotrophic lateral sclerosis
por: Pronto-Laborinho, Ana Catarina, et al.
Publicado: (2021) -
A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology
por: Stanga, Serena, et al.
Publicado: (2018) -
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
por: Vucic, Steve, et al.
Publicado: (2013) -
Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2020)